What does european hospital liability — total IBNR mean?

This represents the total Incurred But Not Reported (IBNR) reserves for the European Hospital Liability segment. It captures the estimated liability for claims that have occurred but have not yet been formally reported to the insurer, serving as a critical indicator of long-term reserve adequacy and actuarial risk.

King Pharmaceuticals KG European Hospital Liability — Total IBNR

Other product segments

General Liability

4,098,200,000%—

Commercial Auto Liability

715,500,000%—

All other lines

551,000,000%—

International

313,500,000%—

Similar metrics at other companies

CNAGeneral Liability — IBNR

341,000,000,000%+19,500,000,000pp

SIGIGeneral liability — IBNR

$769.16M+23.9%

CNAInternational — IBNR

$1.91B—

CNAMedical Professional Liability — IBNR

92,000,000,000%+400,000,000pp

PRA

PRAMedical Professional Liability Claims-Made — Incurred but Not Reported Liabilities (IBNR)

$250.54M+0.5%

CNAOther Professional Liability and Management Liability — IBNR

268,900,000,000%+100,000,000pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — total ibnr.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — total IBNR?: King Pharmaceuticals (KG) reported european hospital liability — total IBNR of 1,391,000,000% in Q4 2025.
What does european hospital liability — total IBNR mean?: This represents the total Incurred But Not Reported (IBNR) reserves for the European Hospital Liability segment. It captures the estimated liability for claims that have occurred but have not yet been formally reported to the insurer, serving as a critical indicator of long-term reserve adequacy and actuarial risk.